The Ionify steroid assay panel, which runs on the cobas i 601 analyzer, joins the previously cleared 25-Hydroxy Vitamin D total assay in Roche's growing US mass spectrometry portfolio.
A University of Warwick study finds AI cancer detection models may rely on statistical correlations rather than true biomarker signals, raising concerns about reliability in clinical pathology applications.
The handheld system supports point-of-care fractional exhaled nitric oxide testing in adults and pediatric patients.
The AI companion analyzes up to five years of personal lab data within the company's patient portal to explain test results and identify health trends.
The Bloodhound BCR::ABL1 assay simultaneously detects and quantifies all four clinically important isoforms in a single run, offering new capabilities for chronic myeloid leukemia management.
